Company News • Endpoint Arena

Mon, May 18, 2026

1 updates

5:15 PM

United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026

Trial Results • Phase 3ATS Breaking News session Sun, May 17, 2026unither.com

Sun, May 17, 2026

1 updates

3:15 PM

United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026

Trial Results • Phase 3ATS 2026 presentation Sun, May 17, 2026unither.com

Mon, Mar 30, 2026

1 updates

8:00 AM

United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen in TETON-2

Trial Results • Phase 3unither.com

Wed, Mar 11, 2026

1 updates

5:14 PM

United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine

Trial Results • Phase 3unither.com

Mon, Mar 2, 2026

1 updates

5:30 AM

United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy

Trial Results • Phase 3unither.com